For the most part, the benefits to stroke patients from physical therapy plateau after about six months. Years after her ...

Below is a brief description of sickle cell disease and the populations most affected by it.SCD is a genetic blood disorder that affects the structure and function of red blood cells. In individuals ...

Net loss (GAAP) widened to $2.6 million, driven by increased expenses from the GPCR Therapeutics USA Inc. acquisition. Management issued a going concern warning, citing $7.9 million in cash and cash ...

Overview: Quality Chemicals supplies HIV medicines to 14 countries in the region, with 17 million treatments sold last year, ...

What Happened: SACHS's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 5,000 shares of Vertex Pharmaceuticals. The total ...

NEW YORK, NY-Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, has been named one of the 100 Most Powerful ...

He recently had the first of two six-hour procedures at Manning Family Children's Hospital to collect his stem cells in order to edit them.

The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...

Precision is advancing the final U.S. investigational new drug (IND)-enabling toxicology studies with an anticipated IND and/or clinical trial application (CTA) filing targeted by the end of 2025 with ...

Intas Pharmaceuticals in collaboration with its global subsidiaries operating under the Accord brand, has solidified its ...

In September, 2025, global stakeholders will convene at the United Nations General Assembly for the fourth High-Level Meeting ...

Indian-origin CEO Reshma Kewalramani has made it to the world's 100 Most Powerful People in Business. Ranked 62 by Fortune ...